(Q51048836)

27 March 2018

title

5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study. (English)

1 reference

27 March 2018

1 reference

1 reference

1

Charles N Bernstein

1 reference

27 March 2018

author name string

Zoann Nugent

series ordinal

2

1 reference

27 March 2018

James F Blanchard

series ordinal

3

1 reference

27 March 2018

language of work or name

English

0 references

publication date

15 March 2011

1 reference

27 March 2018

The American Journal of Gastroenterology

published in

1 reference

27 March 2018

volume

106

1 reference

27 March 2018

issue

4

1 reference

27 March 2018

page(s)

731-736

1 reference

27 March 2018

Colorectal cancer prevention in ulcerative colitis: a case-control study.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

Data quality in an information-rich environment: Canada as an example

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

A research registry: uses, development, and accuracy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

Prevention of colorectal cancer in inflammatory bowel disease: value of screening and 5-aminosalicylates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.50

21 January 2018

Identifiers

DOI

10.1038/AJG.2011.50

1 reference

27 March 2018

1 reference

27 March 2018